| Members |
targetComponentId |
| Cloxacillin sodium 125mg/5mL oral solution (product) |
Product containing precisely cloxacillin (as cloxacillin sodium) 25 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| Clozapine monitoring (finding) |
Monitoring of clozapine therapy |
| Co - Cobalt- dietary |
cobalt |
| Co-beneldopa 12.5mg/50mg dispersible tablet (product) |
Benserazide 12.5 mg and levodopa 50 mg oral tablet |
| Co-beneldopa 25mg/100mg dispersible tablet (product) |
Product containing precisely benserazide 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) |
| Co-beneldopa 25mg/100mg m/r capsule (product) |
Product containing only benserazide and levodopa (medicinal product) |
| Co-beneldopa 25mg/100mg prolonged-release oral capsule (product) |
Product containing only benserazide and levodopa (medicinal product) |
| Co-careldopa 10mg/100mg tablet (product) |
Product containing precisely carbidopa anhydrous (as carbidopa) 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) |
| Co-careldopa 25mg/100mg m/r tablet (product) |
Carbidopa 25 mg and levodopa 100 mg prolonged-release oral tablet |
| Co-careldopa 25mg/100mg tablet (product) |
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 100 mg oral tablet |
| Co-careldopa 25mg/250mg tablet (product) |
Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet (clinical drug) |
| Co-careldopa 50mg/200mg m/r tablet (product) |
Product containing precisely carbidopa 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (clinical drug) |
| Co-codamol 8mg/500mg dispersible tablet (product) |
Product containing precisely codeine phosphate 8 milligram and paracetamol 500 milligram/1 each conventional release effervescent oral tablet (clinical drug) |
| Co-codaprin 8mg/500mg dispersible tablet (product) |
Aspirin and codeine only product in oral dose form |
| Co-trimoxazole 160mg/800mg dispersible tablet (product) |
Sulfamethoxazole 800 mg and trimethoprim 160 mg oral tablet |
| Co-trimoxazole 16mg/80mg/mL infusion solution 10mL ampule (product) |
Sulfamethoxazole 80 mg/mL and trimethoprim 16 mg/mL solution for injection |
| Co-trimoxazole 80mg/400mg dispersible tablet (product) |
Product containing precisely sulfamethoxazole 400 milligram and trimethoprim 80 milligram/1 each conventional release oral tablet (clinical drug) |
| Co-trimoxazole 960mg/10mL intravenous infusion (product) |
Sulfamethoxazole 80 mg/mL and trimethoprim 16 mg/mL solution for injection |
| Coagulation Factor VIIa (cattle) |
Coagulation factor VIIa |
| Coagulation Factor XIIa |
Coagulation factor XIIa |
| Coagulation Factor XIa |
Coagulation factor XIa |
| Coagulation Factor Xa |
Coagulation factor Xa (substance) |
| Coagulation factor IV |
Calcium |
| Coagulation factor IXa |
Coagulation factor IXa |
| Coal tar 10% paint (product) |
Coal tar 100 mg/mL cutaneous solution |
| Coal tar 30% bath emulsion (product) |
Product containing precisely coal tar 300 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
| Coal tar 40% bath emulsion (product) |
Product containing precisely coal tar 400 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
| Coal tar 40% conventional release cutaneous solution (product) |
Product containing only coal tar in cutaneous dose form (medicinal product form) |
| Coal tar extract 2% shampoo (product) |
Product containing precisely coal tar 20 milligram/1 milliliter conventional release cutaneous shampoo (clinical drug) |
| Coal tar ointment |
goudron de houille |
| Coal tar topical solution |
goudron de houille |
| Cocaine - non-pharmaceutical |
Cocaine (substance) |
| Cocaine - pharmaceutical (substance) |
Cocaine (substance) |
| Cocaine 10% nasal drops (product) |
Cocaine 100 mg/mL nasal solution |
| Cocaine 20% eye drops (product) |
Cocaine (as cocaine hydrochloride) 200 mg/mL eye solution |
| Cocaine 4% conventional release eye drops (product) |
Product containing precisely cocaine (as cocaine hydrochloride) 40 milligram/1 milliliter conventional release eye solution (clinical drug) |
| Cocaine 4% preservative-free eye drops (product) |
Product containing precisely cocaine (as cocaine hydrochloride) 40 milligram/1 milliliter conventional release eye solution (clinical drug) |
| Cocaine 5% eye drops (product) |
Product containing precisely cocaine (as cocaine hydrochloride) 50 milligram/1 milliliter conventional release eye solution (clinical drug) |
| Cocaine dependence with current use (disorder) |
dépendance à la cocaïne (trouble) |
| Cocaine hydrochloride - non-pharmaceutical |
Cocaine hydrochloride |
| Cocaine hydrochloride 10% conventional release eye solution |
Product containing only cocaine in ocular dose form (medicinal product form) |
| Cocaine hydrochloride 10% single-use solution (product) |
Product containing only cocaine in ocular dose form (medicinal product form) |
| Cocaine hydrochloride 10% topical solution (product) |
Product containing only cocaine (medicinal product) |
| Cocaine hydrochloride 2.5% conventional release eye solution (product) |
Product containing only cocaine in ocular dose form (medicinal product form) |
| Cocaine hydrochloride 2.5% single-use solution (product) |
Product containing only cocaine in ocular dose form (medicinal product form) |
| Cocaine hydrochloride 4% topical solution (product) |
Cocaine hydrochloride 40 mg/mL cutaneous solution |
| Cocaine viscous 10% conventional release cutaneous solution (product) |
Product containing only cocaine (medicinal product) |
| Cocaine viscous 10% topical solution (product) |
Product containing only cocaine (medicinal product) |
| Cocaine viscous 4% conventional release cutaneous solution (product) |
Cocaine hydrochloride 40 mg/mL cutaneous solution |
| Cocaine viscous 4% topical solution (product) |
Cocaine hydrochloride 40 mg/mL cutaneous solution |
| Cocaine+epinephrine 5%/0.02% eye drops |
Cocaine (as cocaine hydrochloride) 50 mg/mL and epinephrine 200 microgram/mL eye solution |
| Cocaine+homatropine 2%/2% eye drops (product) |
Cocaine (as cocaine hydrochloride) 20 mg/mL and homatropine hydrobromide 20 mg/mL eye solution |
| Cochleo-orbicular reflex (observable entity) |
Auropalpebral reflex finding |
| Coconut - dietary |
Coconut (substance) |
| Cod - dietary |
Cod (substance) |
| Codeine phosphate + promethazine hydrochloride 10mg/6.25mg syrup (product) |
Codeine phosphate 2 mg/mL and promethazine hydrochloride 1.25 mg/mL oral solution |
| Codeine phosphate+kaolin 10mg/3g/10mL mixture (product) |
Product containing precisely codeine phosphate 1 milligram/1 milliliter and kaolin 300 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| Coelenterate |
embranchement des Cnidaires |
| Coenzyme-A transferase |
Coenzyme-A transferase |
| Cognitive impairment caused by ingestible alcohol |
Cognitive impairment caused by ethanol (disorder) |
| Coital sexual orgasm |
Coital sexual orgasm |
| Colestyramine+aspartame 4g/sachet conventional release oral powder (product) |
Product containing only colestyramine (medicinal product) |
| Colestyramine+aspartame 4g/sachet s/f oral powder (product) |
Product containing only colestyramine (medicinal product) |
| Colestyramine+aspartame 4g/sachet s/f oral powder (product) |
Product containing only colestyramine (medicinal product) |
| Colfosceril palmitate 108mg sterile powder for suspension (product) |
Product containing precisely colfosceril palmitate 108 milligram/1 vial powder for conventional release suspension for endotracheopulmonary instillation (clinical drug) |
| Colistimethate sodium 1million international units powder for nebulization |
Colistimethate 40 mg/mL solution for inhalation |
| Colistin sulfate 1.5million units tablet (product) |
Product containing precisely colistin 1.5 million unit/1 each conventional release oral tablet (clinical drug) |
| Colitoxemia |
Sepsis |
| Colitoxicosis |
Sepsis |
| Collagen punctal plug (product) |
Collagen punctal plug (physical object) |
| Collection of 24-hour urine specimen for laboratory (procedure) |
prélèvement d'un échantillon d'urine de 24 heures |
| Collection of specimen by nursing |
Specimen collection |
| Collier's stripes |
Collier's stripes (finding) |
| Coloboma of iris |
Congenital coloboma of iris (disorder) |
| Colon flap |
Flap (substance) |
| Colon/rectum TNM finding (finding) |
American Joint Committee on Cancer allowable value |
| Colonic gland |
Colonic crypt of Lieberkühn |
| Colonna osteotomy for congenital deformity of hip |
Colonna arthroplasty (procedure) |
| Colonoscopy equivocal |
Colonoscopy equivocal (finding) |
| Colony-forming unit |
Stem cell colony-forming unit (cell) |
| Colony-forming unit, basophil |
Colony-forming unit of basophilic lineage (cell) |
| Colony-forming unit, blast (substance) |
Blast colony-forming unit (cell) |
| Colony-forming unit, diffusion chamber |
Diffusion chamber colony-forming unit (cell) |
| Colony-forming unit, eosinophil (substance) |
Colony-forming unit of eosinophilic lineage (cell) |
| Colony-forming unit, erythroid |
Colony-forming unit of erythroid lineage (cell) |
| Colony-forming unit, granulocyte |
Colony-forming unit of granulocytic lineage (cell) |
| Colony-forming unit, granulocyte-erythroid-macrophage-megakaryocyte |
Colony-forming unit of granulocytic-erythroid-macrophagocytic-megakaryocytic lineage (cell) |
| Colony-forming unit, granulocyte-macrophage |
Colony-forming unit of granulocytic-macrophagocytic lineage (cell) |
| Colony-forming unit, granulocyte-monocyte |
Colony-forming unit of granulocytic-monocytic lineage (cell) |
| Colony-forming unit, lymphoid-myeloid |
Colony-forming unit of lymphoid-myeloid lineage (cell) |
| Colony-forming unit, macrophage |
Colony-forming unit of macrophagocytic lineage (cell) |
| Colony-forming unit, megakaryocyte (substance) |
Colony-forming unit of megakarocytic lineage (cell) |
| Colony-forming unit, monocyte |
Colony-forming unit of monocytic lineage (cell) |
| Colony-forming unit, neutrophil-monocyte |
Colony-forming unit of neutrophilic-monocytic lineage (cell) |
| Colony-forming unit, spleen |
Spleen colony-forming unit (cell) |
| Colony-stimulating factor, megakaryocyte (substance) |
thrombopoïétine |
| Color symptom |
Finding of colour of skin |
| Colorado tick fever virus subgroup |
virus de la fièvre à tiques du colorado (organisme) |
| Color symptom |
Finding of colour of skin |
| Colubrid snake |
Family Colubridae - colubrid |
| Columba fasciata (organism) |
Patagioenas fasciata (organism) |
FHIR